Home › Funds › TCG Crossover Management, LLC › TRAX
TCG Crossover Management, LLC position in TRAX
FIRST TRACKS BIOTHERAPEUTICS · Health Care
TCG Crossover Management, LLC reported holding 2,895,304 shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$58.3M, representing 1.40% of its reported portfolio and ranking #21 among its reported holdings. TCG Crossover Management, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's TRAX position evolved
TCG Crossover Management, LLC first disclosed a stake in TRAX in Q2 2026 at 2,895,304 shares (US$58.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 2.90M | $58.25M | New |
About TRAX and 13F data
TRAX (FIRST TRACKS BIOTHERAPEUTICS) is a Health Care company. 155 other funds we track also report a position in TRAX — the largest reported positions include EcoR1 Capital, LLC (US$63.9M), Affinity Asset Advisors, LLC (US$40.9M), Trails Edge Capital Partners, LP (US$30.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRAX
- EcoR1 Capital, LLC 3.17M sh · $63.87M · Q2 2026
- Affinity Asset Advisors, LLC 2.03M sh · $40.88M · Q2 2026
- Trails Edge Capital Partners, LP 1.51M sh · $30.46M · Q2 2026
- Vestal Point Capital, LP 1.01M sh · $20.38M · Q2 2026
- Sanofi 821.92K sh · $16.54M · Q2 2026
- 683 Capital Management, LLC 750.00K sh · $15.09M · Q2 2026
- STEMPOINT CAPITAL LP 622.72K sh · $12.53M · Q2 2026
- Palo Alto Investors LP 603.49K sh · $12.14M · Q2 2026
- Sofinnova Investments, Inc. 565.20K sh · $11.37M · Q2 2026
- Ally Bridge Group (NY) LLC 284.29K sh · $5.72M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 226.00K sh · $4.55M · Q2 2026
- Opaleye Management Inc. 65.00K sh · $1.31M · Q2 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held TRAX?
TCG Crossover Management, LLC has disclosed TRAX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is TCG Crossover Management, LLC's current position in TRAX?
As of Q2 2026, TCG Crossover Management, LLC holds 2.90M shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS), valued at $58.25M, representing 1.40% of its reported portfolio and ranking #21.
Has TCG Crossover Management, LLC been buying or selling TRAX?
In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC newly opened its position in TRAX.
Which other funds hold TRAX?
Other major institutional holders of TRAX include EcoR1 Capital, LLC, Affinity Asset Advisors, LLC, Trails Edge Capital Partners, LP, among 155 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.